Crenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic cholangiocarcinoma progression by blocking VEGFA/DLL4/MMP13 axisSerena Mancarella, Gianluigi Giannelli|Cell Death and Differentiation|2020Cited by 68
CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotypeSerena Mancarella, Gianluigi Giannelli|Journal of Experimental & Clinical Cancer Research|2022Cited by 64
The Tumor Microenvironment Drives Intrahepatic Cholangiocarcinoma ProgressionSerena Mancarella, Gianluigi Giannelli|International Journal of Molecular Sciences|2022Cited by 16